When people hear they have a tumor in the liver, the first thing that comes to mind is major surgery. Yet once you actually go through consultations, it is not uncommon to hear, "Let us try embolization instead of surgery." Its formal name is transarterial chemoembolization, shortened in English to TACE. The name is long and difficult, but the principle itself is surprisingly simple. You find the blood vessel that supplies the liver cancer mass, send chemotherapy directly down that path, and then block the vessel. It is quick to understand if you think of it as cutting off the tumor's supply line so it starves.
Why use this method at all? Unlike normal liver tissue, liver cancer mostly receives its blood from the hepatic artery as it grows. The procedure turns this difference to advantage. Because a thin tube is inserted into the artery and advanced right up to the front of the tumor, the drug concentrates on the lesion rather than spreading throughout the whole body. Compared with whole-body chemotherapy, the burden on other organs tends to be lighter, and it can be attempted even when there are multiple tumors or when the location makes it tricky to use a scalpel. That is why it is commonly recommended for those for whom surgery is difficult and for those whose liver function cannot withstand a large resection.
Picture the process like this. Usually a small puncture is made in the femoral artery near the groin, and a thin tube called a catheter is pushed in through it. Watching the shape of the vessels on a screen, the tube is guided all the way to the end of the hepatic artery, and what guides this is contrast dye and X-ray fluoroscopy equipment. Once it reaches the target vessel, chemotherapy and an embolic material are injected together and the path is blocked. General anesthesia is usually not needed, and many places perform it under local anesthesia. There is almost no pain while the tube goes in, but the moment the drug reaches the tumor you may feel nauseated or a heavy, pulling sensation in your side. The time varies from person to person, but within one to two hours is common.
What actually causes more concern is what comes after the procedure ends. After embolization, a good number of people experience what is called post-embolization syndrome. A mild fever rises, the upper abdomen on the treated side throbs, and appetite drops along with nausea. It is a kind of flu-like reaction that occurs as the tumor tissue dies, so it is nothing to be too alarmed about, but you can feel quite drained for a few days. It is usually managed with painkillers and IV fluids while you wait for it to settle. The spot where the femoral artery was punctured requires you to lie still with your leg straight for several hours to prevent bleeding, and many people find that stretch of time quietly frustrating.
After you are discharged and back home, the key is not to rush recovery. For the first few days, drink plenty of water to flush out the contrast dye quickly, and it is better to put off strenuous exercise and drinking alcohol for a while. And it is often not finished in a single session. About a month later, imaging is used to check how much the tumor has shrunk, and if some remains, the same procedure may be repeated. So there is no need to grow anxious, thinking, "Shouldn't it all be gone in one shot?" Accepting it as one step in treatment makes the mind much more at ease. One thing to remember for certain: if you suddenly develop a high fever, severe abdominal pain, or signs of jaundice, notify the hospital right away.
What is written here is only a general explanation meant to help you understand embolization, and the judgment that fits your own condition should be decided in consultation with your medical team.